Monthly Archives: April 2019

Body of evidence in favour of calcium channel blockers for Alzheimer disease

While the effort to modify Alzheimer disease pathology by reducing the production of beta amyloid protein has largely been ineffective, there is a range of evidence that a widely used class of antihypertensive drug could provide a surprising benefit. Calcium antagonists are some of the most widely prescribed drugs for controlling blood pressure currently on […]